Hello this is the Chinese Translation of white paper
WHITEPAPER
Topic: DCX - Managed Global Payment BlockChain - page 3. (Read 4424 times)
Chinese will bring many investors and supporters, usually in Chinese ann thread, the topic will discussed by mqny people there.
hope the translator of Chinese will moderate the topic nicely.
That's correct, I will more concern in translation campaign because it is good to spread the word about DCX. hope the translator of Chinese will moderate the topic nicely.
Good project, you try to make cryptocurrency stable, but it means that it will not listed in exchange. People only can take profit in ICO, because there is bonus presale.
So it is asset backed token, and the price is keep as is. Its mean that if I buy DCX now with 50% bonus, I definitely get 100% profit. Is this right?
This project is look good. But I will learn more about your project.
UPDATE :
DCX proudly announce about a new advisor.
DCX is growing and supported by Advisor for helping the project.
Andrey Voronkov - Co-founder of SONM
DCX proudly announce about a new advisor.
DCX is growing and supported by Advisor for helping the project.
Andrey Voronkov - Co-founder of SONM
Andre Voronkov is a Scientific researcher, working in the field of computational chemistry, chemoinformatics and medicinal chemistry. \
– PhD degree in bioorganic chemistry and biochemistry
– The completed projects include full-scale drug development of preclinical anti-cancer drug candidates in collaboration with Novo Nordisk and Genentech companies.
Areas of competence include preclinical drug discovery, ADME/Tox optimization, molecular modeling and medicinal chemistry. Expertise in all aspects of chemoinformatics, molecular modeling and drug design. Expertise with virtual screening, library design, QSAR, data mining methods, and modeling tools development, computer-aided drug design, fragment-based approaches, molecular modeling, chemo- and bioinformatics, medicinal chemistry, and target analysis and selection. Optimization of physico-chemical parameters for ADME/Tox and DMPK.
Experienced user of the following software packages: MOE from CCG, Sybyl from Certara, Accelyrs Insight and Discovery studio, OpenEye, Schrödinger suite, Vortex / PipelinePilot. Solid background in chemistry, biology, IT, statistics, and mathematics. Expertise in using HPLC, NMR and MS for organic chemistry applications.
The next fields of research are in scope of the interests:
– Applications development for chemoinformatics and modeling methods and tools.
– Collaboration and research in the interdisciplinary teams of chemists, medicinal chemists, biologists and software developers for the analysis and visualization of scientific data
– Processing and evaluation of commercial and virtual libraries for their suitability for HT screening against targets of interest
– Ligand-based and structure-based models construction for improvement of the compounds potency (using pharmacaphore models/QSAR/multivariate approaches)
– Virtual screening and high-throughput screening methodologies optimization
UPDATE :
DCX proudly announce about a new advisor.
DCX is growing and supported by Advisor for helping the project.
Andrey Voronkov - Co-founder of SONM
DCX proudly announce about a new advisor.
DCX is growing and supported by Advisor for helping the project.
Andrey Voronkov - Co-founder of SONM
Andre Voronkov is a Scientific researcher, working in the field of computational chemistry, chemoinformatics and medicinal chemistry. \
– PhD degree in bioorganic chemistry and biochemistry
– The completed projects include full-scale drug development of preclinical anti-cancer drug candidates in collaboration with Novo Nordisk and Genentech companies.
Areas of competence include preclinical drug discovery, ADME/Tox optimization, molecular modeling and medicinal chemistry. Expertise in all aspects of chemoinformatics, molecular modeling and drug design. Expertise with virtual screening, library design, QSAR, data mining methods, and modeling tools development, computer-aided drug design, fragment-based approaches, molecular modeling, chemo- and bioinformatics, medicinal chemistry, and target analysis and selection. Optimization of physico-chemical parameters for ADME/Tox and DMPK.
Experienced user of the following software packages: MOE from CCG, Sybyl from Certara, Accelyrs Insight and Discovery studio, OpenEye, Schrödinger suite, Vortex / PipelinePilot. Solid background in chemistry, biology, IT, statistics, and mathematics. Expertise in using HPLC, NMR and MS for organic chemistry applications.
The next fields of research are in scope of the interests:
– Applications development for chemoinformatics and modeling methods and tools.
– Collaboration and research in the interdisciplinary teams of chemists, medicinal chemists, biologists and software developers for the analysis and visualization of scientific data
– Processing and evaluation of commercial and virtual libraries for their suitability for HT screening against targets of interest
– Ligand-based and structure-based models construction for improvement of the compounds potency (using pharmacaphore models/QSAR/multivariate approaches)
– Virtual screening and high-throughput screening methodologies optimization
Chinese will bring many investors and supporters, usually in Chinese ann thread, the topic will discussed by mqny people there.
hope the translator of Chinese will moderate the topic nicely.
hope the translator of Chinese will moderate the topic nicely.
Update regarding Smith and crown will be posted soon
Yes I agree with you, I will also monitor the development of this project or not, this project will definitely be good going forward, and the allocation of the bounty hunter lots up to 7500 ETH. and when reaching the softcap if in pre-sale has reached 2000 eth already have a condition. Moreover, supply's not how likely softcap will be achieved
Update regarding Smith and crown will be posted soon
reserved
bounty campaign will be posted shortly.
bounty campaign will be posted shortly.
when will be open the bounty program Sir? Interesting to joined
I see this project seems will be good and success in the future. Good luck your project.
we are planning for technical bounty campaign. please be patient
reserved
bounty campaign will be posted shortly.
bounty campaign will be posted shortly.
when will be open the bounty program Sir? Interesting to joined
I see this project seems will be good and success in the future. Good luck your project.
we are planning for technical bounty campaign. please be patient
At first glance, the project deserves attention. I will study in more detail and, possibly, support you on the ICO.
A good approach for any invester, we are sure we will urn your trust and investment. Thnx
How much is your soft cap? I see, that you end your ICO - when you reach soft cap, but didn't see the numbers.
Our softcap is 2000 ETH which equals 150.000 DCX (50% presale bonus included). Also stated on the website at section "Token information" (bottom left) .
Can someone explain what is going to happen with the remaining tokens not being sold?
May i will all do respect advise you to read the whitepaper before asking questions, this is fully covered in the wp.....
How much is your soft cap? I see, that you end your ICO - when you reach soft cap, but didn't see the numbers.
Do you negotiate with Poloniex about the listing of the tokens?
Hi AshdiD22,
No we are not and we are also not going to unfortunately. Poloniex states the following on their coin info page
Quote
Some takeaways:
We cannot list any token that resembles a security. We suggest token devs familiarize themselves with The Howey Test.
We cannot list any token that resembles a security. We suggest token devs familiarize themselves with The Howey Test.
as DCX token entitles to a claim to monthly receive a part of DCX exchange fee's as stated in whitepaper we do not pass the Howey test which tests if your coin/token acts as a security or not.
I will wright down your enquiry. At the moment we are looking at the possiblities to register DCX Shareholders Token at US SEC office, if we do so we will get DCX on Poloniex exchange.
For the record DCX will be listed on lots of other exchanges, we will send out news updates on which ones after ICO is ended with good results, which is needed for most echanges to be accepted and listed.
Hi guys,
Here you can find the Dutch white paper: https://drive.google.com/file/d/1L0YGKnS0D6d_7ZuxHJR4q7LDAU_WZWOo/view
Here you can find the Dutch white paper: https://drive.google.com/file/d/1L0YGKnS0D6d_7ZuxHJR4q7LDAU_WZWOo/view
Lol die had ik zelf ook wel kunnen schrijven
Do you negotiate with Poloniex about the listing of the tokens?
Jump to: